Form 4: Sukhi Jagpal, Sutro Biopharma Director, Reports Stock Option Grant

Director Sukhi Jagpal reports the acquisition of stock options in Sutro Biopharma, Inc.

Summary

• Sukhi Jagpal, a director of Sutro Biopharma, Inc., filed a Form 4 disclosing changes in beneficial ownership.
• The report details the acquisition of two stock option grants on August 8, 2024.
• One option is for 35,000 shares, vesting monthly from September 8, 2024, and fully vested by August 8, 2027.
• The second option is for 28,959 shares, vesting monthly from September 8, 2024, through May 8, 2025, with the remainder vesting on June 6, 2025, coinciding with the company's 2025 annual meeting.
• Both options have an exercise price of $3.22 and expire on August 8, 2034.
• Following these transactions, Jagpal directly owns 35,000 and 28,959 derivative securities.

Sentiment

Score: 6

Explanation: The document is a neutral regulatory filing. The grant of stock options is generally viewed as a positive incentive for management, but the filing itself doesn't convey strong positive or negative sentiment.

Positives

• The granting of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule incentivizes continued service to the company.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with shareholder value creation.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors and executives in publicly traded companies, particularly in the biotech sector.
• Vesting schedules are typically structured to incentivize long-term commitment and performance.
• The specific terms of the options, such as the exercise price and vesting schedule, are generally determined by the company's compensation committee and are benchmarked against industry peers.

Stakeholder Impact

• The stock option grant could potentially incentivize the director to act in ways that increase shareholder value.
• Employees may view the grant as a positive sign of the company's commitment to its leadership.

Key Dates